Insider Transactions in Q3 2025 at Phibro Animal Health Corp (PAHC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2025
|
Jack Bendheim President and CEO |
SELL
Open market or private sale
|
Indirect |
20,664
-33.69%
|
$826,560
$40.38 P/Share
|
|
Sep 19
2025
|
Jack Bendheim President and CEO |
BUY
Conversion of derivative security
|
Indirect |
30,000
+32.85%
|
-
|
|
Sep 18
2025
|
Jack Bendheim President and CEO |
SELL
Open market or private sale
|
Indirect |
7,022
-18.31%
|
$280,880
$40.26 P/Share
|
|
Sep 11
2025
|
Jack Bendheim President and CEO |
SELL
Open market or private sale
|
Indirect |
3,520
-8.41%
|
$140,800
$40.95 P/Share
|
|
Sep 10
2025
|
Jack Bendheim President and CEO |
SELL
Open market or private sale
|
Indirect |
3,520
-7.75%
|
$144,320
$41.29 P/Share
|
|
Sep 09
2025
|
Jack Bendheim President and CEO |
SELL
Open market or private sale
|
Indirect |
14,080
-23.67%
|
$563,200
$40.33 P/Share
|
|
Aug 15
2025
|
Larry Lee Miller Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,184
+12.84%
|
-
|
|
Aug 15
2025
|
Anthony Andolino Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,793
+50.0%
|
-
|
|
Aug 15
2025
|
Lisa Ann Escudero Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,152
+50.0%
|
-
|
|
Aug 15
2025
|
Jack Bendheim President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,840
+18.08%
|
-
|
|
Aug 15
2025
|
Daniel M Bendheim Exec. VP, Corporate Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
3,964
+50.0%
|
-
|
|
Aug 15
2025
|
Jonathan Bendheim Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,268
+50.0%
|
-
|
|
Aug 15
2025
|
Glenn David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,845
+12.21%
|
-
|
|
Aug 15
2025
|
Judith Weinstein Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,447
+50.0%
|
-
|